"Clinical Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
| Descriptor ID |
D002986
|
| MeSH Number(s) |
E05.318.760.250.500 N05.715.360.775.088.500 N06.850.520.450.250.250
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Clinical Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Clinical Trials as Topic".
This graph shows the total number of publications written about "Clinical Trials as Topic" by people in this website by year, and whether "Clinical Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 3 | 3 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 2 | 3 |
| 2004 | 0 | 4 | 4 |
| 2005 | 1 | 3 | 4 |
| 2006 | 2 | 3 | 5 |
| 2007 | 2 | 3 | 5 |
| 2008 | 0 | 2 | 2 |
| 2009 | 1 | 6 | 7 |
| 2010 | 4 | 2 | 6 |
| 2011 | 1 | 4 | 5 |
| 2012 | 4 | 3 | 7 |
| 2013 | 4 | 4 | 8 |
| 2014 | 6 | 2 | 8 |
| 2015 | 4 | 5 | 9 |
| 2016 | 3 | 7 | 10 |
| 2017 | 4 | 4 | 8 |
| 2018 | 2 | 6 | 8 |
| 2019 | 8 | 4 | 12 |
| 2020 | 1 | 9 | 10 |
| 2021 | 3 | 4 | 7 |
| 2022 | 0 | 5 | 5 |
| 2023 | 1 | 1 | 2 |
| 2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Clinical Trials as Topic" by people in Profiles.
-
Optimization of Timing for Risk-Reducing Salpingectomy and Oophorectomy. Obstet Gynecol. 2025 Jan 01; 145(1):21-30.
-
Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha-expressing recurrent ovarian cancer: An integrated safety summary. Gynecol Oncol. 2024 Dec; 191:249-258.
-
Patient-Reported Outcomes in Clinical Trials: From an Endpoint to an Intervention in Cancer Care. Semin Radiat Oncol. 2023 10; 33(4):358-366.
-
An evaluation of reporting guidelines and Clinical Trial Registry requirements among anesthesiology journals. J Evid Based Med. 2023 06; 16(2):116-119.
-
The impact of COVID-19 on psychiatry research: A cross-sectional analysis of discontinued clinical trials for depressive disorders. Psychiatry Res. 2023 01; 319:114999.
-
Development and validation of a risk score for predicting pericardial effusion in patients undergoing leadless pacemaker implantation: experience with the Micra transcatheter pacemaker. Europace. 2022 07 21; 24(7):1119-1126.
-
Stigmatizing Terminology for Outcomes and Processes (STOP) in Alcohol Research: A Meta-epidemiologic Assessment of Language Used in Clinical Trial Publications. J Addict Med. 2022 Sep-Oct 01; 16(5):527-533.
-
The impact of COVID-19 on otolaryngology research: a cross-sectional analysis of discontinued trials. J Osteopath Med. 2022 04 01; 122(8):393-399.
-
The evaluation of reporting of patient-reported outcomes in MDD: A meta-epidemiological study of clinical trials. J Psychiatr Res. 2022 06; 150:79-86.
-
Diagnostic challenges and disease management in patients with a mild Zellweger spectrum disorder phenotype. Mol Genet Metab. 2021 11; 134(3):217-222.